MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, DNABW made $170,155K in revenue. -$309,106K in net income. Net profit margin of -181.66%.

Income Overview

Revenue
$170,155K
Net Income
-$309,106K
Net Profit Margin
-181.66%
EPS
-$5.64
Unit: Thousand (K) dollars
Revenue Breakdown
    • Cell Engineering Segment
    • Biosecurity Segment-Service
Revenue Breakdown
    • Cell Engineering Revenue
    • Service

Income Statement
2025-12-31
Total revenue
170,155
Cost of revenue-Service
31,521
Cost of revenue-Product
0
Cost of revenue-Product And Service Other
15,451
Research and development
243,773
General and administrative
183,290
Impairment of lease assets
0
Goodwill impairment
0
Restructuring charges
11,398
Total operating expenses
485,433
Loss from operations
-315,278
Interest income
22,616
Interest expense
0
Loss on equity method investments
0
Loss on investments
-16,411
Loss on deconsolidation of subsidiaries
0
Change in fair value of warrant liabilities
0
Other (expense) income, net
-4,527
Total other income (expense)
1,678
Loss before income taxes
-313,600
Income tax benefit
-837
Net loss
-312,763
Foreign currency translation adjustment
3,531
Reclassification of foreign currency translation adjustment realized upon sale of foreign subsidiary
0
Unrealized gain on available-for-sale securities
-126
Total other comprehensive income (loss)
3,657
Comprehensive loss
-309,106
Basic EPS
-5.64
Diluted EPS
-5.64
Basic Average Shares
55,457,676
Diluted Average Shares
55,457,676
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Foreign currencytranslation adjustment$3,531K Unrealized gain onavailable-for-sale securities-$126K Comprehensive loss-$309,106K Total othercomprehensive income (loss)$3,657K Net loss-$312,763K Income tax benefit-$837K Interest income$22,616K Research and development$158,541K Cost ofrevenue-Service$28,897K General andadministrative$27,443K General andadministrative$56,532K Cost of revenue$13,203K Loss before incometaxes-$313,600K Total other income(expense)$1,678K Cell EngineeringSegment$132,746K BiosecuritySegment-Service$37,409K Loss on investments-$16,411K Other (expense)income, net-$4,527K Loss from operations-$95,530K Loss from operations-$18,931K Loss from operations-$315,278K Total revenue$170,155K Total operatingexpenses$485,433K Research and development$243,773K General andadministrative$183,290K Cost ofrevenue-Service$31,521K Cost ofrevenue-Product And Service...$15,451K Restructuring charges$11,398K

Ginkgo Bioworks Holdings, Inc. (DNABW)

Ginkgo Bioworks Holdings, Inc. (DNABW)